Steve Callaghan
Impact in
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Nuclear Receptors and Signaling
- Nerve injury and regeneration
Papers in
-
- RNA regulation and disease 5
- Ubiquitin and proteasome pathways 4
- Neurology 13
- Parkinson's Disease Mechanisms and Treatments 13
- Co-authors
- Ruth S. Slack (24 shared papers)David S. Park (24 shared papers)Hossein Aleyasin (6 shared papers)Maxime W.C. Rousseaux (13 shared papers)Tak W. Mak (5 shared papers)Raymond H. Kim (4 shared papers)Patrice D. Smith (3 shared papers)Hymie Anisman (4 shared papers)
- Journals
- Journal of Neuroscience (6 papers)Journal of Biological Chemistry (6 papers)Proceedings of the National Academy of Sciences (5 papers)Human Molecular Genetics (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- CanadaUnited StatesSouth Korea
In The Last Decade
Steve Callaghan
31 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 86
- Neurology 777
- Cellular and Molecular Neuroscience 613
- Neurology 249
- Developmental Neuroscience 85
- Cell Biology 327
Countries citing papers authored by Steve Callaghan
This map shows the geographic impact of Steve Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Callaghan more than expected).
Fields of papers citing papers by Steve Callaghan
This network shows the impact of papers produced by Steve Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Callaghan. The network helps show where Steve Callaghan may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Callaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 237 | |
| 2 | 2008 | 210 | |
| 3 | 2007 | 210 | |
| 4 | 2012 | 182 | |
| 5 | 2006 | 152 | |
| 6 | 2010 | 145 | |
| 7 | 2007 | 135 | |
| 8 | 2004 | 101 | |
| 9 | 2018 | 85 | |
| 10 | 2001 | 82 | |
| 11 | 2012 | 68 | |
| 12 | 2009 | 64 | |
| 13 | 2015 | 55 | |
| 14 | 2014 | 42 | |
| 15 | 2019 | 39 | |
| 16 | 2007 | 38 | |
| 17 | 2014 | 36 | |
| 18 | 2019 | 33 | |
| 19 | 2013 | 28 | |
| 20 | 2007 | 24 |
About Steve Callaghan
Steve Callaghan is a scholar working on Molecular Biology, Neurology, Cellular and Molecular Neuroscience, Oncology and Physiology, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (13 papers), Cancer-related Molecular Pathways (6 papers), Nuclear Receptors and Signaling (6 papers), RNA regulation and disease (5 papers), Ubiquitin and proteasome pathways (4 papers), Nerve injury and regeneration (4 papers), Autophagy in Disease and Therapy (4 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Neurology (777 citations), Cellular and Molecular Neuroscience (613 citations), Neurology (249 citations), Developmental Neuroscience (85 citations) and Cell Biology (327 citations). Steve Callaghan has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include Ruth S. Slack, David S. Park, Hossein Aleyasin, Maxime W.C. Rousseaux, Tak W. Mak, Raymond H. Kim, Patrice D. Smith, Hymie Anisman, Alvin Joselin and Matthew Mount. Their work appears in journals such as Journal of Neuroscience, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Human Molecular Genetics and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.